febuxostat has been researched along with Myocardial Infarction in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SR; Ha, YJ; Han, M; Kang, EH; Lee, EB; Lee, YJ; Shin, A | 1 |
| Kuo, CF; Li, PR; Liu, JR; See, LC; Tsai, PH | 1 |
| Anzai, T; Fukushima, A; Furihata, T; Higashikawa, K; Kakutani, N; Katayama, T; Kinugawa, S; Kuge, Y; Maekawa, S; Matsumoto, J; Nakajima, T; Nakano, I; Nambu, H; Nio-Kobayashi, J; Obata, Y; Sabe, H; Saito, A; Shirakawa, R; Takada, S; Tsuda, M; Yamanashi, K; Yasui, H; Yokota, T | 1 |
| Cheng, R; Gao, L; Lu, Y; Pan, Y; Wang, B | 1 |
| Choi, HK; Kang, EH; Kim, SC; Lee, EB; Lee, YJ; Shin, A; Song, YW | 1 |
| Kang, EH; Kim, SC | 1 |
| Chen, A; Li, Y; Song, X; Wang, S; Wang, X; Yang, P; Zhao, C | 1 |
| Chang, NC; Lee, TM; Lin, SZ | 1 |
| Hamlin, RL; Kijtawornrat, A; Lolly, JL; Roche, BM; Shemanski, D; Wessale, JL; Zhao, L | 1 |
2 review(s) available for febuxostat and Myocardial Infarction
| Article | Year |
|---|---|
Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta-analysis.
Topics: Allopurinol; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Myocardial Infarction | 2021 |
Cardiovascular Safety of Urate Lowering Therapies.
Topics: Allopurinol; Cardiovascular Diseases; Endothelium; Febuxostat; Gout; Gout Suppressants; Heart Failure; Humans; Hypertension; Hyperuricemia; Myocardial Infarction; Probenecid; Risk; Stroke; Uricosuric Agents; Xanthine Oxidase | 2019 |
7 other study(ies) available for febuxostat and Myocardial Infarction
| Article | Year |
|---|---|
Cardiovascular safety associated with febuxostat versus allopurinol among patients with gout: Update with accumulated use of febuxostat.
Topics: Allopurinol; Cohort Studies; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Myocardial Infarction; Treatment Outcome | 2022 |
Effect of febuxostat on adverse events and mortality in gout in Taiwan: An interrupted time series analysis.
Topics: Allopurinol; Febuxostat; Gout; Gout Suppressants; Humans; Interrupted Time Series Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Retrospective Studies; Taiwan | 2023 |
Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intolerance.
Topics: Animals; Cell Hypoxia; Cell Line; Disease Models, Animal; Enzyme Inhibitors; Exercise Tolerance; Febuxostat; Male; Mice, Inbred C57BL; Mitochondria, Muscle; Muscle Fibers, Skeletal; Muscle Strength; Muscle, Skeletal; Muscular Atrophy; Myocardial Infarction; Reactive Oxygen Species; Ribosomal Protein S6 Kinases, 70-kDa; Time Factors; TOR Serine-Threonine Kinases; Xanthine Oxidase | 2021 |
Comparative cardiovascular risk of allopurinol versus febuxostat in patients with gout: a nation-wide cohort study.
Topics: Aged; Allopurinol; Cardiovascular Diseases; Cohort Studies; Febuxostat; Female; Gout; Gout Suppressants; Humans; Ischemic Attack, Transient; Male; Middle Aged; Mortality; Myocardial Infarction; Myocardial Revascularization; Proportional Hazards Models; Republic of Korea; Stroke | 2019 |
Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis.
Topics: Animals; Animals, Newborn; Apoptosis; Caspase 3; Caspase 9; Cytochromes c; Febuxostat; Heart Function Tests; Heart Ventricles; Hypoxia; Male; Membrane Potential, Mitochondrial; Mice, Inbred C57BL; Mitochondria; Models, Biological; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Necrosis; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction | 2015 |
Effects of urate-lowering agents on arrhythmia vulnerability in post-infarcted rat hearts.
Topics: Animals; Arrhythmias, Cardiac; Febuxostat; GAP-43 Protein; Male; Myocardial Infarction; Myocardium; Nerve Growth Factor; Rats; Rats, Wistar; Superoxides; Tyrosine 3-Monooxygenase; Uric Acid; Uricosuric Agents; Xanthine Oxidase | 2016 |
Chronic xanthine oxidase inhibition following myocardial infarction in rabbits: effects of early versus delayed treatment.
Topics: Allopurinol; Animals; Body Weight; Echocardiography; Enzyme Inhibitors; Febuxostat; Heart Failure; Male; Myocardial Infarction; Myocardium; Organ Size; Rabbits; Thiazoles; Time Factors; Xanthine Oxidase | 2008 |